Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Mol Life Sci ; 57(4): 675-83, 2000 Apr.
Article in English | MEDLINE | ID: mdl-11130465

ABSTRACT

We have recently described an anti-beta2-microglobulin (beta2-m) monoclonal antibody (mAb 14H3) capable of recognizing the epitope 92-99 of the protein in the monomeric native state as well as in the fibrillar polymeric state, but not in the major histocompatibility complex type I (MHCI) anchored to the cell membrane. In the present study, we investigated the molecular basis for the inaccessibility of the C-terminal end of beta2-m in the MHCI complex, and demonstrated that mAb 14H3 binds the soluble fraction of the MHCI complex with a Kd of 0.3 microM. An interaction between the complex and the membrane protects beta2-m from immunological recognition at the MHCI level. This protection from antibody recognition can be weakened by procedures such as heat shock or gamma irradiation that perturb the membrane structure and commit the cell to the apoptotic pathway. mAb 14H3 can recognize MHCI in a transient state that most likely precedes beta2-m shedding and may be proposed as a useful tool for dynamic analysis of MHCI conformational modifications.


Subject(s)
Histocompatibility Antigens Class I/chemistry , Histocompatibility Antigens Class I/immunology , beta 2-Microglobulin/immunology , Antibodies, Monoclonal/immunology , Binding Sites , Cell Membrane/metabolism , Humans , Jurkat Cells , Protein Conformation , Solubility , beta 2-Microglobulin/metabolism
2.
Biochim Biophys Acta ; 1478(2): 232-8, 2000 May 23.
Article in English | MEDLINE | ID: mdl-10825534

ABSTRACT

Complement component C3 plays a key role in the complement-mediated immune defence, and occupies a central position within the complement cascade system. One of its degradation products, C3dg, was purified from rat serum and crystallised in two different crystal forms as N-terminally truncated fragment. Despite the truncation and the lack of a significant portion of the N-terminus as compared to C3d, the structure of the fragment is highly similar to that of recombinant human C3d (Nagar et al., Science 280 (1998) 1277-1281). Structural details of the reactive site have been obtained, suggesting a possible mode of thioester bond formation between Cys-1010 and Gln-1013 and thioester bond cleavage in the transacylation reaction involving His-1126. The truncation at the N-terminus of C3d leads to the exposure of a surface of the molecule that favours dimerisation, so that in both crystal forms, the fragment is present as a dimer, with monomers related by a two-fold axis.


Subject(s)
Complement C3d/chemistry , Animals , Complement C3d/immunology , Complement C3d/isolation & purification , Crystallization , Dimerization , Models, Molecular , Molecular Sequence Data , Peptide Fragments , Protein Conformation , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...